CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 28 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $76,000 | -85.6% | 51,992 | -80.7% | 0.04% | -35.5% |
| Q4 2019 | $529,000 | -61.7% | 270,017 | 0.0% | 0.06% | -65.0% |
| Q3 2019 | $1,382,000 | -20.3% | 270,017 | +11.5% | 0.18% | +47.5% |
| Q2 2019 | $1,734,000 | -28.9% | 242,200 | +31.8% | 0.12% | +6.2% |
| Q1 2019 | $2,440,000 | +149.5% | 183,800 | +47.9% | 0.11% | +68.7% |
| Q4 2018 | $978,000 | +3160.0% | 124,300 | +1000.0% | 0.07% | +1575.0% |
| Q2 2015 | $30,000 | -92.8% | 11,300 | -81.3% | 0.00% | -93.1% |
| Q1 2015 | $417,000 | – | 60,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |